Contact DMCA Privacy

Robuta

https://zejulahcp.com/
Ovarian Cancer Treatment | ZEJULA (niraparib) for HCPs
Learn about ZEJULA (niraparib), a once-daily oral PARP inhibitor for adults with HRD-positive aOC. Find more information about this maintenance option.
ovarian cancertreatmentzejulaniraparibhcps
https://www.mayo.edu/research/clinical-trials/cls-20520637
An Extension Study to Evaluate Subjects Who Have Benefited from Previous Treatment with Niraparib -...
Learn more about services at Mayo Clinic.
extensionstudyevaluatesubjects
https://www.mayo.edu/research/clinical-trials/cls-20429230
Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment - Mayo...
Learn more about services at Mayo Clinic.
studyantitumoractivitysafetyniraparib
https://www.jnj.com/innovativemedicine/emea/magnitude__phase3_niraparib_mCRPC_ASCOGU22
Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus...
the combinationjanssenpresentsnewdata
https://pubmed.ncbi.nlm.nih.gov/37935524/
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in...
NCT05009082; EudraCT Number: 2021-001271-16.
agoovarniraparibaloneversus